NEW YORK, NY / ACCESSWIRE / July 31, 2018 / U.S. markets continued to drop on Monday, as tech sector close in the red weighed by
"The market is punishing companies that don't beat on revenue or earnings, or which give a bad outlook. You need to win on all three to do well, and if you miss, like Facebook did, you get pummeled," said
RDI Initiates Coverage on:
Bristol-Myers Squibb Company
Bristol-Myers Squibb's stock jumped 3.53% Monday, to close the day at $58.93. The stock recorded a trading volume of 8,096,923 shares, which was above its three months average volume of 7,129,855 shares. In the last year, Bristol-Myers Squibb's shares have traded in a range of 49.96 - 70.05. The share price has gained 17.95% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $55.59 is below its 200-day moving average of $58.58. Shares of the company are trading at a Price to Earnings ratio of 105.04. Shares of Bristol-Myers Squibb have gained roughly 6.49
Access RDI's Bristol-Myers Squibb Company Research Report at:
On Monday, shares of Allergan recorded a trading volume of 2,982,683 shares, which was above the three months average volume of 2,360,412 shares. The stock ended the day 3.01% higher at $183.99. The share price has fallen 27.99% from its 52
Access RDI's Allergan plc Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.